Literature DB >> 16461963

Nephrogenic diabetes insipidus.

Jeff M Sands1, Daniel G Bichet.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16461963     DOI： 10.7326/0003-4819-144-3-200602070-00007

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  46 in total

1.  Analysis of 43 cases of Langerhans cell histiocytosis (LCH)-induced central diabetes insipidus registered in the JLSG-96 and JLSG-02 studies in Japan.

Authors:  Yoko Shioda; Souichi Adachi; Shinsaku Imashuku; Kazuko Kudo; Toshihiko Imamura; Akira Morimoto
Journal:  Int J Hematol       Date:  2011-11-17       Impact factor: 2.490

2.  Water, Water Everywhere: A New Cause and a New Treatment for Nephrogenic Diabetes Insipidus.

Authors:  Jeff M Sands
Journal:  J Am Soc Nephrol       Date:  2015-12-28       Impact factor: 10.121

Review 3.  Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.

Authors:  B K Kishore; N G Carlson; C M Ecelbarger; D E Kohan; C E Müller; R D Nelson; J Peti-Peterdi; Y Zhang
Journal:  Acta Physiol (Oxf)       Date:  2015-05-04       Impact factor: 6.311

4.  Nephrogenic diabetes insipidus in mice caused by deleting COOH-terminal tail of aquaporin-2.

Authors:  Peijun P Shi; Xiao R Cao; Jing Qu; Ken A Volk; Patricia Kirby; Roger A Williamson; John B Stokes; Baoli Yang
Journal:  Am J Physiol Renal Physiol       Date:  2007-01-16

5.  P2Y(2) receptors and water transport in the kidney.

Authors:  Bellamkonda K Kishore; Raoul D Nelson; R Lance Miller; Noel G Carlson; Donald E Kohan
Journal:  Purinergic Signal       Date:  2009-03-25       Impact factor: 3.765

6.  Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.

Authors:  Alejandro García Castaño; Gustavo Pérez de Nanclares; Leire Madariaga; Mireia Aguirre; Sara Chocron; Alvaro Madrid; Francisco Javier Lafita Tejedor; Mercedes Gil Campos; Jaime Sánchez Del Pozo; Rafael Ruiz Cano; Mar Espino; Jose Maria Gomez Vida; Fernando Santos; Victor Manuel García Nieto; Reyner Loza; Luis Miguel Rodríguez; Emilia Hidalgo Barquero; Nikoleta Printza; Juan Antonio Camacho; Luis Castaño; Gema Ariceta
Journal:  Eur J Pediatr       Date:  2015-04-23       Impact factor: 3.183

Review 7.  Congenital nephrogenic diabetes insipidus: the current state of affairs.

Authors:  Daniel Wesche; Peter M T Deen; Nine V A M Knoers
Journal:  Pediatr Nephrol       Date:  2012-03-17       Impact factor: 3.714

8.  Novel activators of aquaporin 2 membrane expression for the treatment of nephrogenic diabetes insipidus: less is more. Focus on "High-throughput chemical screening identifies AG-490 as a stimulator of aquaporin 2 membrane expression and urine concentration".

Authors:  Jeff M Sands; Mitsi A Blount
Journal:  Am J Physiol Cell Physiol       Date:  2014-06-18       Impact factor: 4.249

9.  EGF Receptor Inhibition by Erlotinib Increases Aquaporin 2-Mediated Renal Water Reabsorption.

Authors:  Pui W Cheung; Naohiro Nomura; Anil V Nair; Nutthapoom Pathomthongtaweechai; Lars Ueberdiek; Hua A Jenny Lu; Dennis Brown; Richard Bouley
Journal:  J Am Soc Nephrol       Date:  2016-03-09       Impact factor: 10.121

10.  Potential role of purinergic signaling in urinary concentration in inner medulla: insights from P2Y2 receptor gene knockout mice.

Authors:  Yue Zhang; Jeff M Sands; Donald E Kohan; Raoul D Nelson; Christopher F Martin; Noel G Carlson; Craig D Kamerath; Yuqiang Ge; Janet D Klein; Bellamkonda K Kishore
Journal:  Am J Physiol Renal Physiol       Date:  2008-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.